MA26553A1 - Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la - Google Patents

Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la

Info

Publication number
MA26553A1
MA26553A1 MA25299A MA25299A MA26553A1 MA 26553 A1 MA26553 A1 MA 26553A1 MA 25299 A MA25299 A MA 25299A MA 25299 A MA25299 A MA 25299A MA 26553 A1 MA26553 A1 MA 26553A1
Authority
MA
Morocco
Prior art keywords
alkylnitrones
aryl
alpha
same
pharmaceutical compositions
Prior art date
Application number
MA25299A
Other languages
English (en)
Inventor
Judith A Kelleher
Kirk R Maples
Allan I Wilcox
Alina Dykman
Yong-Kang Zhang
Julian Levell
Original Assignee
Centaur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centaur Pharmaceuticals Inc filed Critical Centaur Pharmaceuticals Inc
Publication of MA26553A1 publication Critical patent/MA26553A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/04—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes
MA25299A 1997-10-17 1998-10-15 Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la MA26553A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6232497P 1997-10-17 1997-10-17
US6373697P 1997-10-29 1997-10-29
US9047598P 1998-06-24 1998-06-24

Publications (1)

Publication Number Publication Date
MA26553A1 true MA26553A1 (fr) 2004-12-20

Family

ID=27370256

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25299A MA26553A1 (fr) 1997-10-17 1998-10-15 Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la

Country Status (24)

Country Link
US (5) US6046232A (fr)
EP (1) EP1025079B1 (fr)
JP (1) JP2001520217A (fr)
KR (1) KR20010024520A (fr)
CN (1) CN1281432A (fr)
AR (1) AR015969A1 (fr)
AT (1) ATE288419T1 (fr)
AU (1) AU1083399A (fr)
BR (1) BR9813256A (fr)
CA (1) CA2305798A1 (fr)
DE (1) DE69828895T2 (fr)
ES (1) ES2235374T3 (fr)
HU (1) HUP0004398A3 (fr)
ID (1) ID25543A (fr)
IL (1) IL135646A0 (fr)
MA (1) MA26553A1 (fr)
NO (1) NO20001914L (fr)
NZ (1) NZ503910A (fr)
PL (1) PL340003A1 (fr)
SK (1) SK5512000A3 (fr)
TN (1) TNSN98187A1 (fr)
TR (1) TR200001023T2 (fr)
TW (1) TWI226882B (fr)
WO (1) WO1999020601A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046232A (en) * 1997-10-17 2000-04-04 Centaur Pharmaceuticals, Inc. α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
EP1079820A1 (fr) 1998-05-19 2001-03-07 Centaur Pharmaceuticals, Inc. Medicament a base de benzamide, destine au traitement des affections inflammatoires de l'intestin
US6083989A (en) * 1999-05-18 2000-07-04 Centaur Pharmaceuticals, Inc. Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
ATE271384T1 (de) * 1998-05-19 2004-08-15 Renovis Inc Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
EP1098873B1 (fr) 1998-07-17 2004-05-26 Renovis, Inc. Composes de alpha-2(2-hydroxyphenyl)nitrone, compositions pharmaceutiques les renfermant et leur utilisation dans le traitement des inflammations
US6730700B2 (en) 1998-12-02 2004-05-04 Renovis, Inc. 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
UA66401C2 (en) 1998-12-02 2004-05-17 Sentor Pharmaceuticals Inc 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same
BR9904931A (pt) * 1999-10-18 2001-06-12 Sergio Teixeira Ferreira Inibição de amiloidoses
AU1917301A (en) * 1999-11-18 2001-05-30 Centaur Pharmaceuticals, Inc. Aryl nitrone therapeutics and methods for treating inflammatory bowel disease
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
US6664297B1 (en) 2000-10-18 2003-12-16 Universidade Federal Do Rio De Janeiro Methods for inhibition and dissolution of amyloidoses by administration of compositions comprising 2,4-dinitrophenol
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
AU2002253857A1 (en) 2001-01-08 2002-09-04 Centaur Pharmaceuticals, Inc. Use of aryl nitrone compounds in methods for treating neuropathic pain
JP2004527520A (ja) * 2001-04-02 2004-09-09 パノラマ リサーチ，インコーポレイティド 治療剤としての抗酸化ニトロキシドおよびニトロン
US7115666B2 (en) * 2002-10-15 2006-10-03 Renovis, Inc. Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
US6762322B1 (en) 2002-12-20 2004-07-13 Goodyear Tire & Rubber Company Preparation of nitrone derivatives
AU2004241107A1 (en) * 2003-05-15 2004-12-02 Cutanix Corporation Compositions containing a combination of a pharmaceutical agent or a cosmetic agent and an oxy group-bearing aromatic aldehyde
US20050059638A1 (en) * 2003-08-04 2005-03-17 Kelly Michael G. Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
WO2006121560A2 (fr) 2005-04-06 2006-11-16 Adamas Pharmaceuticals, Inc. Procedes et compositions pour le traitement des pathologies associees au systeme nerveux central
FR2898602B1 (fr) 2006-03-17 2012-06-22 Ts Pharma Nouveaux derives amphiphiles de l'alpha-c-phenyl-n-tert butyl nitrone
CN101468970B (zh) * 2008-04-25 2011-05-11 暨南大学 一种硝酮类化合物及其制备方法和在制药中的应用
EP2506709B2 (fr) 2009-12-02 2019-10-09 Adamas Pharmaceuticals, Inc. Compositions d'amantadine et procédés d'utilisation associés
CN102311396B (zh) * 2010-07-05 2015-01-07 暨南大学 一种吡嗪类衍生物和其制备方法及在制药中的应用
CA3043905A1 (fr) 2011-01-07 2012-07-12 Allergan, Inc. Compositions comprenant des benzaldehydes substitues et leur utilisation pour eclaircir la peau ou traiter des troubles d'hyperpigmenation et d'hypermelanose
WO2014204933A1 (fr) 2013-06-17 2014-12-24 Adamas Pharmaceuticals, Inc. Compositions d'amantadine et procédés d'utilisation
CN107522635B (zh) * 2017-06-22 2020-02-14 东北师范大学 一类n-环丙基硝酮衍生物及其制备方法
CN107488090B (zh) * 2017-06-22 2020-06-02 东北师范大学 一种n-环丙基硝酮化合物的高效催化不对称制备方法
CN109438288B (zh) * 2018-10-22 2021-05-07 河南中医药大学 一种n-硝酮取代芳香酰胺衍生物及其制备方法
CN112479936A (zh) * 2020-12-16 2021-03-12 怀化学院 一种苯偶酰衍生物硝酮的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666754A (en) * 1965-11-06 1972-05-30 Dainippon Pharmaceutical Co 2-(5-nitrofuryl) nitrone derivatives
US3834073A (en) * 1971-05-03 1974-09-10 Scm Corp Phenyl nitrone derivatives useful as seed protectants
US3849934A (en) * 1971-05-03 1974-11-26 Scm Corp Alpha-aryl-n-lower alkyl nitrone-containing compositions useful as anti-fungal agents
US3903049A (en) * 1974-01-30 1975-09-02 Goodyear Tire & Rubber Oxidation resistant sulfur curable rubbery polymers
US3917700A (en) * 1974-01-30 1975-11-04 Goodyear Tire & Rubber Nitrone compounds
IT1133010B (it) * 1980-05-15 1986-07-09 Sigma Tau Ind Farmaceuti Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo
GB2137619A (en) * 1983-03-30 1984-10-10 Gerald Scott Nitrone compounds and stabilised rubber compositions containing them
US5723502A (en) * 1985-07-18 1998-03-03 Proctor; Peter H. Topical spin trap composition and method
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
DE68917946T2 (de) * 1988-01-29 1995-01-05 Peter H Proctor Haarwachstumanregung mit Nitroxyd und anderen Radikalen.
EP0496796B1 (fr) * 1989-10-17 1994-08-31 Oklahoma Medical Research Foundation Procede et compositions inhibant les troubles associes aux lesions oxydatives des tissus
ATE209908T1 (de) * 1991-06-18 2001-12-15 Oklahoma Med Res Found RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
US5292746A (en) * 1991-09-12 1994-03-08 Merrell Dow Pharmaceuticals Inc. Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock
US5455272A (en) * 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
ATE349420T1 (de) * 1995-11-17 2007-01-15 Florida Internat University Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung
TW429241B (en) * 1996-09-26 2001-04-11 Sumitomo Pharma Nitrone derivatives
US6046232A (en) 1997-10-17 2000-04-04 Centaur Pharmaceuticals, Inc. α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
PL340003A1 (en) 2001-01-15
BR9813256A (pt) 2000-08-29
AR015969A1 (es) 2001-05-30
EP1025079A1 (fr) 2000-08-09
US20030087957A1 (en) 2003-05-08
IL135646A0 (en) 2001-05-20
JP2001520217A (ja) 2001-10-30
TNSN98187A1 (fr) 2005-03-15
AU1083399A (en) 1999-05-10
WO1999020601A1 (fr) 1999-04-29
HUP0004398A2 (hu) 2001-05-28
NO20001914D0 (no) 2000-04-12
ATE288419T1 (de) 2005-02-15
CA2305798A1 (fr) 1999-04-29
CN1281432A (zh) 2001-01-24
US6433008B1 (en) 2002-08-13
EP1025079B1 (fr) 2005-02-02
NO20001914L (no) 2000-06-02
ES2235374T3 (es) 2005-07-01
KR20010024520A (ko) 2001-03-26
NZ503910A (en) 2002-09-27
SK5512000A3 (en) 2001-01-18
TWI226882B (en) 2005-01-21
ID25543A (id) 2000-10-12
US20050124691A1 (en) 2005-06-09
DE69828895T2 (de) 2006-01-19
TR200001023T2 (tr) 2000-11-21
US6441032B1 (en) 2002-08-27
DE69828895D1 (de) 2005-03-10
US6046232A (en) 2000-04-04
HUP0004398A3 (en) 2001-11-28

Similar Documents

Publication Publication Date Title
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
DZ2086A1 (fr) Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
BR1100824A (pt) Composto e composição farmacêutica
ATE263558T1 (de) Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
ID24654A (id) Formulasi farmasi omeprazola
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
DE69524592T2 (de) 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
BR9509688A (pt) Composto e composição farmacêutica
FI973229A (fi) Uusi farmaseuttinen koostumus
ID29294A (id) Komposisi farmasi
MA26531A1 (fr) Composition pharmaceutique
IT1274655B (it) Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico
ATE228839T1 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
PT986537E (pt) Novos compostos heteroetinilenos e composicoes farmaceuticas e cosmeticas contendo-os
ID25857A (id) Komposisi farmasi
ZA989238B (en) Benzimidazole compounds pharmaceutical compositions containing the compounds and their use
FR2739382B1 (fr) Fraction ribosomale et composition la contenant
BR9606066A (pt) Composto e formulação farmacêutica
ID23531A (id) Komposisi farmasi